National Tuberculosis Advisory Committee multi-drug resistant tuberculosis: Information Paper (October 2007)
DOI:
https://doi.org/10.33321/cdi.2007.31.45Keywords:
multi-drug resistant tuberculosisAbstract
This document is endorsed by the National Tuberculosis Advisory Committee. Multi-drug resistant tuberculosis (MDRTB) is defined as a strain of Mycobacterium tuberculosis with resistance to at least isoniazid (H) and rifampicin (R), the two key drugs in TB treatment.
Downloads
References
Bastian I, Portaels F (eds). Multidrug-resistant tuberculosis. Kluwer Academic Publishers, Dordrecht, 2000.
Caminero JA. Treatment of multidrug tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829–837.
Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Morb Mortal Wkly Rep 2005;54 (No. RR–17).
Francis J. Curry National Tuberculosis Center and California Department of Health Services, 2004: Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. Available from: http://www.nationaltbcenter.edu
The National Collaborating Centre for Chronic Conditions. Tuberculosis: the clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians of London, 2006. Available from: http://www.nice.org.uk/guidance/CG33
World Health Organization. Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. 2006. Available from: http://www.who.int/tb/publications/2006/en/index.html
Downloads
Published
How to Cite
License
Copyright (c) 2007 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
